Introduction
The constitutive expression of class II MHC antigens is documented on a diverse but limited number of cell types in thymus, spleen and lymph nodes, and these cells play an essential role in the presentation of peptide antigens to class ll-restricted T cells. Although expression of class II molecules is an intrinsic property of these antigen-presenting cells, the level of expression can be modulated by extrinsic mediators: IL-4 and IL-10 increase expression by B cells (1,2) but IFN-yhas the reverse effect (3) . In contrast IL-4 and IFN-yboth enhance expression by macrophages (4, 5) while glucocorticoids diminish it (6) . Expression of these MHC antigens can also be induced by IFNyand tumour necrosis factor on cells in non-lymphoid tissues (7) (8) (9) (10) , but the functional significance of this inducible expression is generally less well established. Expression of class II MHC antigens by Tcells has been extensively studied in human and mouse, but the literature on this topic for the laboratory rat is more limited. Further, in contrast to the situation with regard to class II MHC antigen expression on most cell types, the effects of cytokines and glucocorticoids on class II expression by T cells appears not to have been studied.
Whilst a small portion of resting human T cells may express class II antigens (11) , expression has been observed predominantly on activated T cells. Human antigen-specific T cells (12, 13) have been shown to synthesize and express class II antigens on their cell surfaces as have T cells activated in a mixed leukocyte culture (MLC) (14, 15) or with phytohaemagglutinin or pokeweed mitogen (12) . The class II antigens expressed by these T cells have also been demonstrated to be very similar or identical in structure to those expressed by syngeneic B cells (16) .
Earlier studies reported expression of class II antigens by mitogenically activated mouse T cells (17, 18) , but in later reports this expression was attributed to passive acquisition of antigen from accessory cells (19) . It is possible that such passive acquisition is a consequence of the forcible dissociation of clusters of T cells and dendritic cells that accompanies the preparation of the T cells for analysis. Alloreactive T cell clones (20) , cells activated in a MLC (21) and mitogen activated T cells (22) have all been observed to acquire class II antigens from accessory cells. The binding of anti-class II antibodies to activated rat T cells has been demonstrated in vivo during induction of experimental allergic encephalomyelitis (23) and in vitro by T cells activated either allogeneically or with concanavalin A (23, 24) . In one of these studies, care was taken to exclude the possibility that the observed class II antigen expression was a consequence of passive acquisition from syngeneic antigen-presenting cells (23) .
The present study was prompted by the observation that T cells recovered from the lymph of PVG.RT1
U rats with induced insulin-dependent diabetes mellitus (IDDM) expressed high levels of class II antigens (25) . In an immune system which had been highly dysregulated by adult thymectomy and repeated low doses of y-irradiation it was found that a significant population of CD4 + thoracic duct lymphocytes (TDL) expressed class II antigens, in contrast to the situation in a normal healthy animal in which very few T cells expressed them. This in vivo expression could not be ascribed to the forcible, non-physiological dissociation of activated T cells from class II + antigen-presenting cells since TDL occur naturally as a fully dispersed population of lymphocytes. However, to unambiguously establish that activated rat T cells do synthesize these molecules an in vitro system was set up in which forcible dissociation was avoided and in which purified populations of T cells, free of syngeneic non-T cells, could be activated. To confirm that the activated T cells were synthesizing the class II antigen found on their surface use was made of the fact that there appears to be an obligatory requirement for transcription of the class II transactivator (CIITA) (26, 27) , for class II antigen expression to occur.
These studies confirmed previous results by others (23, 24) that a subpopulation of activated rat (but not mouse) T cells expresses class II antigens that they themselves synthesize, but further experiments were carried out to determine the effects of cytokines and glucocorticoids on the size of this subset. In the course of these experiments it was found that CD4 + L-selectin + thymocytes, that were homogeneous by all available criteria, were heterogeneous when examined for the phenotype expressed after activation. It remains to be determined whether this finding implies a functional heterogeneity among these cells.
Methods

Animals
PVG and PVG.RT1
U rats aged between 6 and 14 weeks were obtained from our own specific pathogen-free breeding facilities. CBA and BALB/c mice aged between 10 and 14 weeks were from the Dunn School of Pathology mouse breeding unit. mAb Mouse mAb used in this study were as follows: 0X21 mAb (lgG1, anti-human C3b inactivator) (28), 0X8 (anti-rat CD8) (29) , W3/25 (anti-rat CD4) (30) , 0X3 (anti-rat class II MHC, RT1B lu .RT1B is the rat homologue of mouse I-A) (31), 0X6 (anti-rat class II MHC) (31), 0X12 (anti-rat Ig) (32), 0X22 (anti-CD45RC) (33), 0X76 (anti-rat class II MHC, RT1B C ) (unpublished).
Rat mAb used were as follows: YTS105 (anti-mouse CD8) (34), YTS177 (anti-mouse CD4) (34), RA3.62B (anti-mouse B cell CD45) (35) .
The following mAb were added to cultures to block biological activity of cytokines: DB1 (10 |ig/ml) was used to block rat IFN-y, and was kindly provided by Dr P. van der Meide (TNO, Rijswijk, The Netherlands); 0X81 hybridoma tissue culture supernatant (TCS) (Ramirez et al., in preparation) was used to block the biological activity of rat IL-4.
Isolation of T lymphocyte subpopulations
T cell populations were negatively selected from rat thymus or lymph node and mouse spleen using a rosetting technique described elsewhere (36 + cells were further purified by cell sorting on a FACS II on the basis of CD4 expression after labelling with YTS177 and fluoresceinconjugated rabbit anti-rat Ig (RAR-FITC). CD4 + mouse cells used for RT-PCR were further purified after culture by cell sorting on the basis of CD4 expression. The purity of all isolated cells was analysed on a FACScan (Becton Dickinson Immunocytometry Systems) by labelling of pre-and postdepletion samples with FITC-conjugated rabbit-anti-mouse Ig, cross-reactive with rat Ig (RAMR-FITC).
CD4
+ T cells were isolated from the TDL of prediabetic rats by rosette depletion and then by cell sorting on a FACS II on the basis of CD4 expression after labelling with W3/25 and RAM-FITC.
MLC
The purity of rat thymic and lymph node T cells used for culture was at least 80 or 98% respectively, and that of mouse splenic T cells was at least 98%.
Responding + cells (A) was determined by two-colour labelling of samples with mAb for CD4 (W3/25-biotin + streptavidin-PE) and class II (OX6 + RAM-Fab-FITC). cDNA synthesized by reverse transcription of mRNA from whole TDL and purified CD4 + T cells of protected diabetic rats was used in a PCR employing primers for class II mRNA (B) Five 3.16-fold dilutions of cDNA, startma at 110, were used with class II primers Three 10-fold cDNA dilutions with primers for p-actin, starting at 110, were used as controls. CD4* T cells were determined to be 98% pure and the 2% contaminant was shown to be class II antigen negative (data not shown). PCR reactions using dilutions of whole TDL cDNA representative of the contaminant failed to give a product which could account for that seen with the cDNA of CD4+ T cells
Rat primary cultures were supplemented with the following: rat IL-4 (37) at 1000 U/ml, rat IFN-y (kindly provided by Dr P. van der Meide) at 500 U/ml, dexamethasone (Sigma) at 10" 6 M.
Flow cytofluorography
Two-colour flow cytofluorographic analysis of lymphocytes from MLC was performed essentially as described (36) . Briefly, 10 6 cells were incubated in 50 nl of hybridoma TCS at 4°C for 30 min, washed with PBS containing 0.2% BSA and 10 mM NaN 3 . OX21 (anti-human C3b inactivator) was used as negative control labelling for mouse mAb throughout. Mouse mAb labelling was developed with either RAM-Fab-FITC or RAM-phycoerythrin (RAM-PE) (Serotec, Oxford, UK) at 4°C for 30 min followed by incubation at 4°C for 20 min with 5% normal mouse serum. Rat mAb labelling was developed using rabbit anti-rat FITC (RAR-FITC) (Serotec) at 4°C for 30 min. CD4 + blasts from rat MLC were labelled with fluorescein-conjugated mAb W3/25 at 4°C for 30 min.
Samples were analysed on a FACScan, calibrated weekly with dilute sheep erythrocytes (Becton Dickinson Immunocytometry Systems). All histograms were generated by positively gating on CD4 + cells, by analysis of listmode data using Lysys II (Becton Dickinson Immunocytometry Systems).
RT-PCR
Total RNA was prepared from 2x10 6 whole TDL or 2X10 6 CD4 + T lymphocytes by RNAzol B extraction (Biogenesis, Poole, UK) and mRNA reverse transcribed to cDNA using oligo-dT priming and M-MLV reverse transcriptase (Gibco/ BRL) in a final volume of 40 nl as described (38) . For semiquantitative PCR analysis of class II MHC and CIITA mRNA levels, 10-fold dilutions of the cDNA were amplified in 50 |il reaction volumes containing per reaction 1 unit of Taq DNA polymerase (Boehringer Mannheim, Mannheim, Germany), 0.5 ng of oligonucleotide primers and 2.5 mM MgCI 2 . Primer sequences for rat (3-actin (38) have been previously described. For rat class II MHC they were 5'-CAG TCA CAG AAG GCG TTT ATG-3' and 5'-GAT CGC AGG CCT TGA ATG ATG-3' and for rat and mouse CIITA were 5'-CAG ACC CAG AGG CTG AGA AAC-3' and 5'-GTA CAA GCT CAG CCT TAG GAG-3'. These primers were designed to specifically amplify cDNA fragments representing mature class II mRNA transcripts of 279 bp and mature CIITA mRNA transcripts of 353 bp. Cycle conditions were 93°C for 1 min, 60°C for 2 min and 72°C for 3 min using 20 cycles for p-actin and 30 cycles for class II MHC and CIITA. Then, 10 |il of amplified product was separated by electrophoresis on 1.5% agarose minigels, visualized by ethidium bromide staining and saved as a digital image (Appligene Imager; Appligene, Pleasanton, CA).
Induction of IDDM in PVG.RT1
U rats IDDM was induced in PVG.RT1 U rats as has been previously described (25) . Briefly, male rats aged 6 weeks were thymectomized and given four 250 rad doses of y-irradiation at 2 week intervals starting 2 weeks after thymectomy. Onset of diabetes was assessed by monitoring rat weight and measuring rat blood glucose levels. Prediabetic rats were used as sources of T cells for phenotyping 5 weeks after the last irradiation and after at least one other in the same group had clinical presentation of IDDM at that time.
synthesis by T cells of prediabetic
Results
Class II antigen PVG.RT1 U rats
A normal strain of laboratory rat, PVG.RT1 U , was induced to develop diabetes by a protocol of thymectomy and Y-irradiation, as previously described (25) . In this model, rats thymectomized at 6 weeks of age and subsequently given four 250 rad doses of 137 Cs ^-irradiation develop autoimmune IDDM within a few weeks of the last dose of irradiation. The disease can be completely prevented by the i.v. injection of CD45RC l0W CD4 + TDL from normal syngeneic donors. Such recipients are referred to as 'protected' rats. In the present experiments, CD4 + cells was purified from TDL of protected rats and class II antigen expression analysed by flow cytometry (Fig. 1A) . A significant population of CD4 + T cells from these rats expressed high levels of class II antigens not seen on CD4 + cells from the TDL of normal rats (data not shown). These data confirm results from previous reports of class II antigen expression in PVG.RT1 U rats in which diabetes had been induced (25) . To further examine this expression, RNA was extracted from a sample of CD4 + TDL of protected rats. Using RT-PCR it was shown that these in vivo activated T cells contained mRNA for class II MHC antigens, suggesting that the T cells were themselves synthesizing the antigens that they expressed (Fig. 1B) .
Activated T cells both acquire alloantigens and synthesis class II antigens
As all the preceding results were obtained in a syngeneic system and the presence of mRNA alone does not necessarily imply protein synthesis, there was no way of distinguishing whether the class II antigen expression on activated T cells in the diabetic rats was acquired from other cells or synthesized by the T cells themselves. In order to address this question, CD4
+ T cells were rigorously depleted of any cells expressing class II MHC antigens and activated in a primary MLC. CD4 + blasts were then analysed by flow cytofluorography using allospecific mAb which could distinguish between class II antigens of the responder or stimulator genotype. CD4 + T cell blasts from a typical MLC between CD4+ lymph node cells of PVG rats and irradiated splenocytes of PVG.RT1 U rats were stained for class II antigens using the allospecific mAb, both immediately after the primary MLC ( Fig. 2A and B ) and after expansion of the culture in IL-2 ( Fig.  2C and D) . The expression of allogeneic class II antigens by a population of CD4 + T cell blasts was detected after the primary MLC by labelling cells with 0X3 mAb, specific for stimulator strain class II antigens ( Fig. 2A) . This acquisition of MHC antigen by T blasts was only transient: on separating these cells from a 3.5 day MLC, on Isopaque-Ficoll and culturing them for a further 3 days in IL-2 but in the absence of fresh allogeneic stimulator cells, no acquired alloantigen could be detected (Fig. 2C) . The loss of acquired class II antigens during the 3 day culture period in IL-2 can probably be attributed to the turnover of cell surface molecules during this time and to the cytokine-driven expansion in cell number.
In the same experiment, only a small population of CD4 + blasts from the primary MLC were labelled by an anti-class II mAb (0X76) specific for class II MHC antigens of the responder strain (Fig. 2B ). After the culture had undergone expansion in exogenous IL-2 for 3 days, however, 23.5% of CD4 + blasts were labelled by the same anti-class II mAb (Fig. 2D) .
As the present data show, in MLC using rat peripheral T cells as responder cells the class II antigens found on the activated T cells were of two origins: acquired from the stimulator cell populations and, in confirmation of previously published data (23, 24) , synthesized by the T cells themselves (Fig. 2) . Given that dendritic cells have fine ramifying processes which may not remain intact during cell deaggregation the possibility has to be considered that the acquisition from the stimulators is an artefact of cell preparation (19) . This caveat cannot be applied to the expression of syngeneic class II antigens on the T cells in these experiments since only the rigorously purified T cells were of responder strain genotype.
Rat but not mouse CD4 + T cells express CIITA mRNA upon activation in MLC
In further support of these observations, cDNA prepared from rat CD4 + T cells activated in primary MLC was analysed by PCR for the expression of CIITA mRNA, a transcriptional factor required for class II MHC expression. cDNA prepared from mouse CD4 + T cells activated in the same way was used as a negative control. CD4 + T cells from PVG rats were activated in a primary MLC by irradiated splenocytes of PVG.RT1" rats for 4 days. Actin .-L--to-•607bp Fig. 3 . Activated CD4 + T cells of rat but not mouse express mRNA for CIITA. cDNA was synthesized by reverse transcription of mRNA from rat and mouse CD4 + T cells activated in a 4 day primary MLC and further cultured in IL-2 for 3 days Neat and two 10-fold dilutions of cDNA from these cultures were used in a PCR employing primers for rat and mouse CIITA mRNA. Reactions with the same dilutions of cDNA prepared from rat and mouse splenocytes were used as positive controls Three 10-fold cDNA dilutions with primers for f*-actin, starting with undiluted cDNA, were used to ensure similar amounts of rat and mouse cDNA were being compared mRNA by CD4 + T cells from rat primary MLC could be readily detected, where as no mRNA could be detected in the cDNA prepared from CD4 + T cells of the mouse primary MLC (Fig.  3) . cDNA prepared from rat and mouse splenocytes were used as positive controls and were found to contain readily detectable amounts of CIITA mRNA transcripts (Fig. 3) .
Effect of cytokines on class II MHC expression by T cells
Experiments were carried out to determine whether class II MHC antigen expression by activated T cells was influenced by the presence of cytokines in primary cultures.
In a typical experiment, CD4 + cells from PVG rats were activated in a primary MLC with irradiated splenocytes from a PVG.RT1 U rat, either in the presence or absence of IL-4. After 3.5 days of culture, viable cells were isolated over an Isopaque-Ficoll gradient and cultured for a further 3 days in exogenous IL-2, after which CD4 + blasts could be two-colour stained for the expression of syngeneic class II antigens.
In experiments in which CD4 + thymocytes were activated in a primary MLC and expanded in IL-2, 37% of CD4 + thymocyte blasts were labelled by an anti-class II antigen mAb (0X76) in the absence of any additives in the primary cultures (Fig. 4A) . However, in CD4 + thymocyte MLC with IL-4 present in the initial culture, 79% of CD4 + blasts expressed class II antigens after the 3 day culture expansion in IL-2 (Fig. 4A) . While the percentage of thymocyte blasts expressing class II antigen was subject to some variation (Figs 4A, 5A and 6C), the relative increase observed in cultures supplemented with IL-4 was not. The size of the subset of CD4 + thymocytes, when activated in the presence of IL-4, that expressed class II antigens was always 2-to 2.5-times larger than in control cultures lacking IL-4 (Figs 4A, 5B and 6D). Similar results were also obtained when CD4 + TDL were activated in primary MLC using the same combination of rat strains as the previous experiment. The frequency of CD4 + blasts expressing class II antigens in primary MLC expanded in 3 days culture with IL-2 was increased from 25% in the absence of IL-4 to 87% when IL-4 was added to the primary culture (Fig. 4B) .
A large proportion of CD4 + CO^RC* 19 * T cells express class II MHC antigens on activation
Expression of CD45RC has been a useful marker in the definition of functionally distinct subsets of CD4 + T cells (39) . In order to determine the contribution of these subsets to class II antigen expression, CD4 + TDL were cell sorted on the basis of CD45RC expression and activated in MLC by irradiated splenocytes from PVG.RT1 U rats. After expansion of blasts in 3 days culture with IL-2, in both CD45RC tow and CD45RC hl9h CD4 + MLC, expression of class II antigens (Fig.  4C ) was increased over that of MLC of unfractionated CD4 + TDL (Fig. 4B) . However, in parallel MLC with IL-4 present, only a small but repeatable increase in expression of class II antigens by CD45RC low CD4 + cells was observed in contrast to much larger increases seen in cultures of CD45RC hl8h CD4 + cells (Fig. 4C) . In these experiments, the increase in class II expression induced by IL-4 in MLC of CD45RC h '9 h CD4 + TDL (Fig. 4C ) closely resembled that of CD4+CD8" thymocytes (Fig. 4A) , a naive population of T cells, both of which were distinct from the small increase in class II antigen expression observed by CD45RC k3W CD4 + cells in the presence of IL-4. These data suggest that IL-4 has a greater effect on the induction of class II antigens by naive as compared to memory CD4 + T cells. However, in experiments where no exogenous IL-4 was added to the MLC, the IL-4 neutralizing mAb 0X81 did not reduce class II expression (data not shown), suggesting that endogenous synthesis of IL-4 was playing no significant role in class II induction. The data do not allow a distinction to be made between selective expansion of class A. Rat CD4+ thymoctyes U rats, to determine the effects of glucocorticoids on class II expression by CD4 + blasts Samples were two-colour stained for syngeneic class II and CD4 after cultures had been expanded in IL-2. The effects of dexamethasone were determined for primary MLC in which CD4 + thymocytes were cultured in the absence (A) and presence of IL-4 (B) Similarly, the effects of dexamethasone on class II antigen expression by blasts from primary MLC using CD4 + lymph node cells was determined for cultures in the absence (C) and presence (D) of IL-4.
IFN-y, diminished the frequency of class ll + blasts from 17 to 8%. This change, though small, was seen in two further experiments.
Corticosteroids modulate cytokine-induced up-regulation of class II antigens on T cell blasts
MLC were performed between CD4
+ thymocytes or CD4 + lymph node T cells of PVG rats as responder cells and splenocytes of PVG.FTTI" rats as stimulators. Some of the primary cultures contained dexamethasone, or IL-4, or a mixture of the two. Viable lymphocytes from these cultures were isolated and incubated for a further 3 days in IL-2 after which blasts were analysed for class II antigen expression. A modest increase in the proportion of cells expressing class II antigens was observed in thymocyte blasts which had been cultured with dexamethasone: the frequency increased from 16 to 24% (Fig. 5A) . In addition to this, the marked increase in class II antigen expression observed with the addition of IL-4 was further increased when IL-4 and dexamethasone were added to primary cultures of thymocytes: 68% of thymocyte blasts expressed class II antigens with this combination in contrast to 41% with IL-4 alone (Fig. 5B) . The effect of dexamethasone on lymph node CD4 + T cells (Fig. 5C ) was less than that on CD4 + thymocytes (Fig.  5A) . However, in complete contrast to thymocyte blasts, the addition of dexamethasone to tymph node MLC containing + lymph node cells of PVG rats and irradiated splenocytes of PVGRT1 U rats expanded in culture with IL-2 were two-colour stained for class II antigens (0X6 + RAM-PE) and CD8a chain (OX8-FITC) (A) as were blasts from similar cultures in the presence of IL-4 (B). Using the same rat strains, CD4 + thymocytes were activated in a primary MLC in the absence (C) and presence (D) of IL-4, and then expanded in further culture with IL-2 before samples were two-colour stained for class II antigens and CD8cc chain expression IL-4 reduced the frequency of T blasts expressing class II antigens from a figure of 62% with IL-4 alone to 17% (Fig.  5D ). This latter figure is virtually the same as that observed when neither IL-4 or dexamethasone were added to the cultures.
Differential expression of class II antigens and CD8a chain
It has been established that rat GD4 + T cells activated by concanavalin A in the presence of dexamethasone express CD8a chain and that this is synthesized by the cells themselves. It has also been shown that this expression is inhibited by the inclusion of IL-4 in the culture medium (40) . To determine the relationship between the expression of CD8a chain and of class II antigen by CD4 + T cells activated by alloantigens, a primary 3 day MLC was set up between CD4 + lymph node T cells of PVG rats as responders and irradiated splenocytes of PVG.RT1 U strain animals as stimulators. After isolating the viable lymphocytes at the end of the primary MLC and incubating them for an additional 3 days in IL-2 the cells were two-colour stained for the expression of class II antigens (OX6-PE) and CD8a chain (OX8-FITC). Figure 6(A) shows the dot display resulting from this staining. Three principal populations of blast cells were apparent; 17% were class H + CD8cr, 7% were class irCD8a + and 74.5% were class ll~CD8or. Virtually no cells expressed both surface antigens.
The distribution of expression of both class II antigens and CD8a chain was affected by addition of IL-4 to the primary MLC (Fig. 6B) . As already described in this report, the inclusion of IL-4 in the MLC markedly increased class II antigen expression on CD4 + T cell blasts (Fig. 4B) . In the present experiment the increase was from 18.5 to 82% of all blast cells. This increase in class II expression was associated with a reduction in CD8a chain expression, resulting in only 0.5% of blasts being class ll~CD8a + compared with 7% in cultures not containing exogenous IL-4 ( Fig. 6A and B) . The effects of IL-4 on both class II and CD8a chain expression were also observed on blasts from similar MLC using PVG CD4 + thymocytes as responders. IL-4 increased class II expression as already noted, but also reduced CD8a chain expression from a frequency of 32 to 2.5% ( Fig. 6C and D) . A dichotomy of class II and CD8a chain expression, similar to that described in lymph node cultures (Fig. 6A) , was also observed when thymocyte blasts from MLC with IL-4 were two-colour labelled for class II and CD8a chain (Fig. 6C) . The reduction, induced by IL-4, in the frequency of T blasts expressing CD8<x chain was consistent with the previous results using concanavalin A as the activating stimulus (40) .
Discussion
Two novel results derived from this study. First, class II MHC antigen expression on activated rat CD4 + T cells is influenced by the presence of cytokines and glucocorticoids during activation. Second, that CD4 + CD8~ thymocytes are found to be phenotypically heterogeneous on activation with respect to their expression of class II MHC antigens and CD8a chain.
CD8a chain expression by rat CD4 + T cells has already been reported (24, 40 ) but this present study shows that peripheral rat CD4 + T cell blasts form three subsets, i.e. class H + CD8cr, class irCD8cr and class irCD8a + (Fig. 6) . The relative magnitudes of these phenotypes were reciprocally influenced by IL-4 and corticosteroids: the frequency of class ll + cells was increased by IL-4 but diminished by corticosteroids (Fig. 5) . However, previous data (40) show these two mediators had the reverse effects on the frequency of CD8ct + T cells. As already noted, with respect to class II antigen induction, the steroid hormone effect was dominant in that very little antigen was expressed by peripheral T blasts activated in a mixture of hormone and IL-4 (Fig. 5) . The developmental and functional significance of these three populations remains to be studied but given that human class ll + T cells have been reported to function as antigenpresenting cells these cells might be expected to promote immune responses. Consistent with this interpretation and with the anti-inflammatory action of corticosteroids is the finding, already noted, that these steroids reduced the frequency of T cell blasts expressing class II antigens. The significance of the concomitant increase in the frequency of blasts that were CD8a + is not understood. It is not known whether these latter cells play an anti-inflammatory role in vivo but it has already been reported that rat T lines and human T cell clones with this phenotype prevent the in vitro activation of encephalitogenic T cells (41) and Mycobacterium lepraereactive T cells (42) respectively.
The heterogeneity, with respect to class II antigen expression by activated peripheral T cells, was mirrored by CD4 + thymocyte blasts. Further to this, a subset of thymocyte blasts expressed the CD8a chain, leading to further phenotypic variation (Rg. 6C and D). In principle this variation of surface phenotype might be a reflection of differences in the maturity of CD4 + CD8"thymocytes but this interpretation is improbable: first because the variation was found among the Thy-1 10 * Lselectin + subset of these cells, i.e. the most mature ones (data not shown). Second, because a similar heterogeneity was found among peripheral CD4 + T cells. If differential class II and CD8a chain expression on activated peripheral T cells is indicative of a functional heterogeneity, then these data suggest that a functional specialization of T cells may already be determined in non-activated CD4 + CD8~ thymocytes. Intraepithelial lymphocytes that are CD4 + CD8a + CD5 + are found in euthymic, but not athymic, rats suggesting that these cells are derived from T cell precursors of thymic origin (43) . It is possible that the subpopulation of CD4 + thymocytes which expresses the CD8a chain upon activation (Fig. 6C  and D) forms the precursors of these CD4 + CD8a + CD5 + intraepithelial lymphocytes. The presence of these cells in the thoracic duct of rats is compatible with this interpretation since T cell blasts from this duct have been shown to ' home' to the intestine (44, 45) . However, CD4 + CD8 + T cells have also been found in the spleens of immunized rats (46) and further work is required to establish the functions of these cells.
Messenger RNA for CIITA, a factor important in the control of class II antigen expression, was readily detected in CD4 + T cells activated in primary MLC (Fig 3) . This expression of CIITA by activated rat T cells suggests that these cells can play an antigen-presenting role because it has been shown in the human to be important in the regulation not only of class II MHC gene expression, but also of other genes involved in antigen processing and presentation, specifically invariant chain and HLA-DM (47) . It is well established that human class ll + T cells can present antigens to class IIrestricted T cell clones (48, 49) . In confirmation of the results of others (19) the data shown in Fig. 4 support the conclusion that mouse T cells do not synthesize class II antigens. However, consistent with the postulated role of CIITA in class II antigen expression (26) , recent work has demonstrated that this failure of expression can be reversed by transfecting mouse T cell clones with the human CIITA gene (50) .
As shown in Fig. 1 , rat CD4 + T cells activated in vivo were also found to express class II MHC antigens. Although it is not possible in this case to exclude passive acquisition from other class ll + cells, the fact that the T cells contained mRNA for these antigens supports the view that this was not the case. Attempts to detect mRNA for CIITA in these in vivo activated cells was unsuccessful: possibly this mRNA decays before the activated cells are released into the lymph.
The physiological significance of antigen presentation by T cells remains to be established but as activated T cells 'home' to sites of inflammation they may provide a recruitable form of antigen-presenting cells. Moreover, if a T cell is secreting a cytokine at the time that it is acting as an antigenpresenting cell, then the T cell to which antigen is presented will be activated in a very special microenvironment which may influence its own cytokine repertoire (51) . This possibility raises a number of questions particularly with regard to the cytokines synthesized by T h 0 T cells if these can be activated by class II + T cells and to the relevance of the finding that both IL-4 and IFN-y increased class II expression on rat T cells. It remains to be determined whether the cytokines secreted by T cells induced to express class II antigens by IL-4 differed from those for which IFN-y was the inducing agent (Fig. 4) . Perhaps relevant to this discussion is the fact that the consequences, for the 'responding' T cell, of antigen presentation by human class II + T cells is controversial with both activation of the 'responding' cell (48, 49) and anergy induction being reported (52) .
